classification, glioblastoma, mass spectrometry imaging, prognosis, SpiderMass technology, microproteomics, signaling pathways
Spatially resolved proteomic, Alternative proteins, Protein mutations, FFPE tissues, Fimbria, p53 signature, STIL, STIC, HGSC, Ovarian cancer, SpiderMass, lipids, FASN, FADH
Spatially resolved proteomic, Alternative proteins, Ghost proteome, Protein mutations, FFPE tissues, Fimbria, p53 signature, STIL, STIC, HGSC, ovarian cancer
entinel Lymph Nodes, Endometrial Cancer, Proteomic, Small prot, Ghostproteome, Protein mutations, diagnosis
Tumor heterogeneity, spatially resolved MALDI mass spectrometry imaging, microproteomics, spatially-resolved proteomic, luminal breast cancers, clonal theranostics, functional clones, proteome, mutated proteins, alternative proteins, drug target discovery, drug repurposing